Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Ko 1173
2. Ko-1173
3. Ko1173
4. Koe 1173
5. Koe-1173
6. Koe1173
7. Mexiletene
8. Mexiletine
9. Mexitil
10. Mexitil Pl
11. Mexityl
12. Novo Mexiletine
13. Novo-mexiletine
1. 5370-01-4
2. Mexiletine Hcl
3. Mexitil
4. Mexiletene Hydrochloride
5. Mexiletine (hydrochloride)
6. Katen
7. 1-(2,6-dimethylphenoxy)-2-propanamine Hydrochloride
8. 1-(2,6-dimethylphenoxy)propan-2-amine Hydrochloride
9. Ko 1173 Cl
10. 2-propanamine, 1-(2,6-dimethylphenoxy)-, Hydrochloride
11. Koe-1173 (hydrochloride)
12. Mexiletine-d6 Hydrochloride
13. Ko1173
14. Nsc-758639
15. Ko-1173
16. 1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride
17. 2-(2-aminopropoxy)-1,3-dimethylbenzene Hydrochloride
18. Ko-1173-cl
19. 1-methyl-2-(2,6-xylyloxy)ethylammonium Chloride
20. Ko-1173 Cl
21. 1-(2,6-dimethylphenoxy)-2-propylamine Hydrochloride
22. 606d60is38
23. Ncgc00094121-01
24. Dsstox_cid_25783
25. Dsstox_rid_81125
26. Dsstox_gsid_45783
27. 1-methyl-2-(2,6-xylyloxy)ethylamine Hydrochloride
28. 1-(2,6-dimethylphenoxy)-2-aminopropane Hydrochloride
29. Chebi:6917
30. (+-)-1-methyl-2-(2,6-xylyloxy)ethylamine Hydrochloride
31. Smr000326711
32. Cas-5370-01-4
33. 1-(2,6-xylyloxy)-2-aminopropane
34. Sr-01000075986
35. Ncgc00015659-06
36. Mfcd00216024
37. R-(-)-mexiletine Hydrochloride
38. Ko 1173
39. (2s)-1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride
40. Mexiletine, Hcl
41. 1-(2,6-xylyloxy)-2-aminopropane Hydrochloride
42. Prestwick_666
43. Einecs 226-362-1
44. Mexitil (tn)
45. Schembl42226
46. Mls001056756
47. Mls002222239
48. Mls002548872
49. Spectrum1503929
50. Mexilitene Hydrochloride
51. Mexiletine Hydrochloride, Powder
52. Chembl1200606
53. Dtxsid2045783
54. Ethylamine, 1-methyl-2-(2,6-xylyloxy)-, Hydrochloride
55. Unii-606d60is38
56. Hms1568b04
57. Pharmakon1600-01503929
58. 2-propanamine, 1-(2,6-dimethylphenoxy)-, Hydrochloride, (+-)-
59. Bcp28602
60. Hy-a0093
61. Tox21_111249
62. Tox21_500784
63. Mexiletine Hydrochloride ( Ge 98%)
64. Mexiletine Hydrochloride ( Ge 99%)
65. Mexiletine Hydrochloride [mi]
66. Nsc758639
67. S4225
68. Mexiletine Hydrochloride (jp17/usp)
69. Mexiletine Hydrochloride [jan]
70. Akos009139802
71. Tox21_111249_1
72. Tox21_111249_2
73. Ac-4260
74. Ac-8240
75. Ccg-213246
76. Lp00784
77. Mexiletine Hydrochloride [usan]
78. Nc00682
79. Nsc 758639
80. Sb79359
81. Mexiletine Hydrochloride [mart.]
82. Mexiletine Hydrochloride [vandf]
83. Mexiletine Hydrochloride [usp-rs]
84. Mexiletine Hydrochloride [who-dd]
85. Ncgc00015659-14
86. Ncgc00094121-02
87. Ncgc00094121-03
88. Ncgc00094121-04
89. Ncgc00261469-01
90. 5370-01-4 (hcl)
91. As-13790
92. Mexiletine Hydrochloride [usan:usp:jan]
93. 1-(2,6-dimethylphenoxy)-2-propanamine Hcl
94. Eu-0100784
95. Ft-0672397
96. Ft-0672398
97. M2040
98. Sw196821-3
99. En300-53944
100. Mexiletine Hydrochloride [orange Book]
101. D00639
102. M 2727
103. Mexiletine Hydrochloride [ep Monograph]
104. Mexiletine Hydrochloride [usp Impurity]
105. Mexiletine Hydrochloride [usp Monograph]
106. 370m014
107. A829739
108. Mexiletine Hcl;ko-1173; Ko 1173; Ko1173
109. Sr-01000075986-1
110. Sr-01000075986-6
111. W-105713
112. Q27107357
113. 1-(2,6-dimethylphenoxy)-2-propanamine Hydrochloride, 97%
114. (+/-)-1-methyl-2-(2,6-xylyloxy)ethylamine Hydrochloride
115. 2-propanamine, 1-(2,6-dimethylphenoxy)-, Hydrochloride (1:1)
116. 2-propanamine, 1-(2,6-dimethylphenoxy)-, Hydrochloride, (+/-)-
117. Mexiletine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
118. Mexiletine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
Molecular Weight | 215.72 g/mol |
---|---|
Molecular Formula | C11H18ClNO |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 3 |
Exact Mass | 215.1076919 g/mol |
Monoisotopic Mass | 215.1076919 g/mol |
Topological Polar Surface Area | 35.2 Ų |
Heavy Atom Count | 14 |
Formal Charge | 0 |
Complexity | 139 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Mexiletine hydrochloride |
Drug Label | Mexiletine hydrochloride is an orally active antiarrhythmic agent. It is a white to off-white crystalline powder with slightly bitter taste, freely soluble in water and in alcohol. Mexiletine hydrochloride has a pKa of 9.2. The chemical name of mexil... |
Active Ingredient | Mexiletine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 200mg; 250mg; 150mg |
Market Status | Prescription |
Company | Teva |
2 of 2 | |
---|---|
Drug Name | Mexiletine hydrochloride |
Drug Label | Mexiletine hydrochloride is an orally active antiarrhythmic agent. It is a white to off-white crystalline powder with slightly bitter taste, freely soluble in water and in alcohol. Mexiletine hydrochloride has a pKa of 9.2. The chemical name of mexil... |
Active Ingredient | Mexiletine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 200mg; 250mg; 150mg |
Market Status | Prescription |
Company | Teva |
Namuscla is indicated for the symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders.
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Voltage-Gated Sodium Channel Blockers
A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)
C01BB02
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Mexiletine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mexiletine, including repackagers and relabelers. The FDA regulates Mexiletine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mexiletine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mexiletine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mexiletine supplier is an individual or a company that provides Mexiletine active pharmaceutical ingredient (API) or Mexiletine finished formulations upon request. The Mexiletine suppliers may include Mexiletine API manufacturers, exporters, distributors and traders.
click here to find a list of Mexiletine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mexiletine DMF (Drug Master File) is a document detailing the whole manufacturing process of Mexiletine active pharmaceutical ingredient (API) in detail. Different forms of Mexiletine DMFs exist exist since differing nations have different regulations, such as Mexiletine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mexiletine DMF submitted to regulatory agencies in the US is known as a USDMF. Mexiletine USDMF includes data on Mexiletine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mexiletine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mexiletine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Mexiletine Drug Master File in Japan (Mexiletine JDMF) empowers Mexiletine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Mexiletine JDMF during the approval evaluation for pharmaceutical products. At the time of Mexiletine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Mexiletine suppliers with JDMF on PharmaCompass.
A Mexiletine CEP of the European Pharmacopoeia monograph is often referred to as a Mexiletine Certificate of Suitability (COS). The purpose of a Mexiletine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Mexiletine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Mexiletine to their clients by showing that a Mexiletine CEP has been issued for it. The manufacturer submits a Mexiletine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Mexiletine CEP holder for the record. Additionally, the data presented in the Mexiletine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Mexiletine DMF.
A Mexiletine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Mexiletine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Mexiletine suppliers with CEP (COS) on PharmaCompass.
A Mexiletine written confirmation (Mexiletine WC) is an official document issued by a regulatory agency to a Mexiletine manufacturer, verifying that the manufacturing facility of a Mexiletine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Mexiletine APIs or Mexiletine finished pharmaceutical products to another nation, regulatory agencies frequently require a Mexiletine WC (written confirmation) as part of the regulatory process.
click here to find a list of Mexiletine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mexiletine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mexiletine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mexiletine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mexiletine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mexiletine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mexiletine suppliers with NDC on PharmaCompass.
Mexiletine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mexiletine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mexiletine GMP manufacturer or Mexiletine GMP API supplier for your needs.
A Mexiletine CoA (Certificate of Analysis) is a formal document that attests to Mexiletine's compliance with Mexiletine specifications and serves as a tool for batch-level quality control.
Mexiletine CoA mostly includes findings from lab analyses of a specific batch. For each Mexiletine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mexiletine may be tested according to a variety of international standards, such as European Pharmacopoeia (Mexiletine EP), Mexiletine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mexiletine USP).
LOOKING FOR A SUPPLIER?